Globe Life price target raised to $133 from $132 at JPMorgan

JPMorgan analyst Jimmy Bhullar raised the firm’s price target on Globe Life to $133 from $132 and keeps an Overweight rating on the shares. The firm says the company’s “strong” results affirm its positive view of Globe Life. Results were marked by an earnings beat, strong trends in both the life and health businesses, and upside in share repurchases, the analyst tells investors in a research note. JPMorgan likes the company’s “superior financial profile, defensive business mix, and attractive valuation.”